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Abstract
Background: Paragangliomas affecting the filum terminale are extremely rare, benign tumors. The
literature yielded thirty-two cases of paraganglioma in this site.
Case presentation: A 49 year-old-man, whose presenting symptoms were low back pain and left
leg weakness, was diagnosed as having a paraganglioma of the filum terminale. The clinical,
histological and radiological characteristics of this case, that brings the total number of cases
described to 33, are discussed in the light of published data.
Conclusions: This extremely rare pathology can usually be successfully treated by total surgical
resection, which represents the gold standard. In the event of incomplete removal, assiduous long-
term follow-up is mandatory.
Introduction
Paragangliomas affecting the filum terminale are
extremely rare, benign tumours and only 32 cases have
been reported in the international literature to date: their
characteristics are summarized in Table 1. In the present
study, another case of paraganglioma of filum terminale is
described. The patient was a man aged 49 whose initial
symptoms consisted of low back pain, radicular pain and
left leg weakness. The clinical onset, histopathological fea-
tures and radiological appearance of this pathological
entity are discussed in the light of published data.
Case description
This 49 year-old man was admitted with a 3-month his-
tory of increasing left leg weakness accompanied by pro-
gressive low back pain that radiated to the left leg. Painful
symptoms were worsened by movement, coughing and
upper body rotation. Sphincter dysfunction was absent.
Neurological evaluation revealed tenderness in the region
of the paravertebral muscles: a straight raise test of the left
leg produced posterior thigh pain at 30°. Moderate weak-
ness of the left leg was also observed and dorsal flexion of
the foot in the area innervated by L5, revealed a 1/5 reduc-
tion of strength. Pinprick sensation was diminished but
no dermatomal distribution was identified. Tendon
reflexes, peri-anal sensitivity and anal tone were normal.
Magnetic resonance imaging of the lumbosacral spinal
segment, before and after Gadolinium administration,
disclosed an L4-L5 oval shaped lesion measuring 3.3 × 2
× 1 cm. The lesion was intradural and extramedullary and
was surrounded by bands of low signal intensity on T1
and T2-weighted images [fig.1, fig.2]; it presented marked
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Table 1: Review of the literature from 2007 to 2009. 
AUTHORS AGE AND SEX SYMPHTOMS DURATION TREATMENT RECURRENCE
Igren et Al 58 F LBP + sciatica 17 yrs GTR no
Sonneland 32 M LBP 7 mos GTR no
62 M LBP + sciatica 6 wks GTR no
52 M LBP 3 yrs STR + RXT recurrence after 9 yrs
57 M LBP + sciatica 7 yrs STR no
67 F LBP + sciatica 1 yr GTR no
49 M LBP + sciatica 6 yrs GTR + RXT no
61 M LBP + sciatica 14 mos GTR no
47 F LBP + sciatica 1 yrs STR + RXT recurrence after 1 yr
50 M LBP + sciatica 3 wks GTR no
71 F LBP + sciatica 7 yrs GTR no
56 M paraparesys 1 yrs GTR no
52 F LBP + sciatica 3 mos GTR + RXT no
53 M LBP + sciatica 2 yrs GTR + RXT no
48 F LBP + sciatica 3 yrs GTR no
36 M LBP NS GTR no
39 M LBP 15 yrs GTR no
48 M LBP + sciatica 1,5 yrs GTR no
40 F LBP + sciatica 2 yrs GTR no
50 F LBP + sciatica 15 yrs GTR no
59 M LBP + sciatica 2 yrs GTR no
58 F LBP + sciatica 7 mos GTR no
66 F LBP + sciatica many yrs GTR no
62 F LBP + sciatica many mos GTR no
39 F LBP + sciatica 10 yrs GTR + RXT no
30 F LBP + sciatica 4,5 yrs GTR no
69 F claudicatio 1 yrs GTR no
Russel et Al 61 F LBP many yrs GTR noWorld Journal of Surgical Oncology 2009, 7:95 http://www.wjso.com/content/7/1/95
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contrast enhancement after gadolinium administration.
There were no signs or symptoms indicating catecho-
lamine hyper-secretion, such as hypertension, psycho-
motor distress or headache. Therefore, in the light of the
published data [1], blood laboratory tests to measure the
levels of dopamine, epinephrine, noradrenaline and
vanillymandelic acid were not deemed necessary. A stand-
ard L4-L5 laminectomy was performed to gain access to
the intradural lesion of the filum terminale. Was then
removed "en bloc" via a standard durotomy [Fig. 3]. The
lesion had the appearance of an irregular-shaped nodule
of the dimension previously indicated by MRI [fig.4]. it
had an elastic consistency and was well-encapsulated and
vascularised, adhering to the filum terminale but not to
any other structures. During "en bloc" removal, the filum
was resected cranially to the lesion, bluntly dissecting it
from the caudal roots which appeared displaced but
showed no evidence of infiltration. The patient made an
excellent postoperative recovery. The pain and weakness
in his left leg regressed immediately and completely and
by the second day after surgery ha was able to walk with-
out aid. Gadolinium-enhanced MRI of the lumbosacral
region confirm total excision of the lesion and no evi-
dence of pathological enhancement was observed [fig.5,
fig 6]. on the sixth postoperative day the patient was dis-
charged. Histological evaluation of the tumour showed it
to be made up of uniform cells arranged in large lobules,
or smaller nests, known as "Zellballen". The aggregated
chief cells were surrounded by capillaries, present
throughout the lesion. There was a flattened layer of sus-
tentacular cells, positive for S100 [fig 7] which encom-
passed both the lobules and the "Zellballen".
Immunohistochemical testing gave a positive reaction for
chromogranin in the chief cells [fig. 8].
Discussion
Paraganglioma is a neuro-endocrine tumour, it had a neu-
roectodermal origin and derives from the embryonic sym-
56 F progressive paraplegia 10 days GTR no
Moran et Al 22 F LBP NS GTR no
44 M LBP NS GTR no
Sousa et Al 51 M LBP + sciatica 3 yrs GTR no
Landi et Al 49 M sciatica + weakness at lower left limb 3 mos GTR no
Demographic aspects of previous 32 cases of paraganglioma of filum terminale, addicted with the our case.
Table 1: Review of the literature from 2007 to 2009.  (Continued)
Preoperative MRI Figure 1
Preoperative MRI. Axial T1 weighted images with Gd-DTPA showed an enhancing well defined lesion at L4-L5 levelWorld Journal of Surgical Oncology 2009, 7:95 http://www.wjso.com/content/7/1/95
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pathetic and parasympathetic nervous system. The first
authors to describe this pathological entity were Miller
and Torack in 1970, denominating it a secretory ependy-
moma [2], whereas Lerman was the first to coin the term
paraganglioma of the cauda equina in 1972 [3]. The great
majority of paragangliomas (85-90%) arise in the adrenal
gland whereas extra-adrenal tumours are principally situ-
ated in the jugular glomus of the carotid body [4]. Para-
gangliomas with an extra-spinal localization may be
multiple and have a higher incidence in subjects with a
positive family history since an association with Von Hip-
pel Lindau disease and MEN II has been observed. In the
central nervous system, the most common extra spinal
localizations of paraganglioma are the petrous ridge, pin-
eal gland and sella turcica [5-8]. The spinal localization is
uncommon, with an incidence in the general population
calculated at 0.07 per 100.000 inhabitants. Tumours
affecting the carotid body and glomus region are usually
parasympathetic whereas the spinal variety are typically
sympathetic. In the spine, these tumours most commonly
occur in the cauda equina and filum terminale region,
with a slight male prevalence. They are believed to arise
from sympathetic neurons which originate in the lateral
horn of the spinal cord and follow the course of the nerve
roots [1,9,10]. Another possible locus of tumour origin
consists of the heterotopic neurons that lie along the
branches proximal to the sympathetic trunk. In the lum-
bar spine the origin of these lesions could be the paragan-
preoperative MRI Figure 2
Preoperative MRI. Sagittal T2 and T1 weighted images with Gd-DTPA.
Intraoperative picture of the lesion, after durotomy Figure 3
Intraoperative picture of the lesion, after durotomy.World Journal of Surgical Oncology 2009, 7:95 http://www.wjso.com/content/7/1/95
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glia situated in the cauda equina. However, since it has
been suggested [11] that some components of the diffuse
neuro-endocrine system are the product of a local differ-
entiation and do not derive from neural crest tissue, the
possibility that ependymal cells play a role in the develop-
ment of these lesions cannot be ruled out. The cauda
equina localization of paraganglioma has been well-doc-
umented. In the filum terminale, however, this tumour is
much rarer and English-language databases have yielded
only 32 cases to date [1,12,13]. Biologically, these lesions
are generally benign. A genetic basis has been suggested
on the strength of observations of familiarity and an asso-
ciation with leiomyosarcoma, chordoma or pituitary ade-
noma. Regarding their onset, the mean patient age is 46
years and clinical presentation usually consist of low back
pain, sometimes associated with radicular pain. A cauda
equina syndrome is unusual, despite the fact that the
tumour takes up the whole diameter of the spinal canal.
Sensory and motor deficits are also uncommon. Inconti-
nence (urine and faeces) is relatively rare [14,15]. The fea-
tures of the case we observed were concordant with the
published data in that the patient had a 3-month history
of worsening low back pain and radicular pain with a
moderate left leg weakness but no sphincter dysfunction.
The role of MRI in the diagnosis and treatment of this con-
dition is paramount, owing to the abundance of anatom-
ical information it provides, although a correct diagnosis
may pose some problems. On T1-weighted images, the
lesion usually has an isointense appearance, whereas it is
hyperintense on T2-weighted sequences with enhance-
ment after Gadolinium administration. These features are
common to other intradural lesions, such as schwanno-
mas, mixopapillary ependymomas, ependymomas, men-
ingiomas, metastatic tumours and dermoid tumours or
lipomas [14,16]. In the diagnostic work-up of paragangli-
oma, two observations may be helpful for differentiation:
1) a defect in the serpiginous structure between the conus
and the lesion, suggesting dilatation of the serpentine ves-
sels, which is uncommon in schwannomas and ependy-
momas. 2) a hypointense appearance of the tumour rim
on T2-weighted sequences, suggesting para-magnetic
effects caused by hemosiderin, which is typical of vascular
tumours since hemosiderin discolouration is a sign of
prior hemorrhage (3). Currently, the functional imaging
Macroscopic aspect of the lesion after the en-block removal Figure 4
Macroscopic aspect of the lesion after the en-block 
removal.
Postoperative MRI: sagittal T1, T2 and T1 with Gd-DTPA  scans that showed the complete removal of the lesion Figure 5
Postoperative MRI: sagittal T1, T2 and T1 with Gd-
DTPA scans that showed the complete removal of 
the lesion.
Postoperative MRI: axial T1, T2 and T1 with Gd-DTPA scans Figure 6
Postoperative MRI: axial T1, T2 and T1 with Gd-
DTPA scans.World Journal of Surgical Oncology 2009, 7:95 http://www.wjso.com/content/7/1/95
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method preferred for localizing extra-adrenal or adrenal
paragangliomas is Scintigraphy with I-MIBG. Although
there can be no doubt of the high level of sensitivity and
specificity of this method, it also has some drawbacks.
These consist of relatively high levels of irradiaton expo-
sure and failure to identify non-secreting paragangliomas,
in other words the majority of those situated in the cauda
equina and filum terminale [1]. Surgical treatment aims at
completely excision of the lesion that is usually well-
encapsulated, as in the case we observed. Histopathologi-
cal diagnosis is based on the characteristics typical of par-
aganglioma, namely an organoid or "Zellballen"
organization of argyrophilic cells which are circumscribed
by vascular stroma, immunohistochemical testing with a
positive reaction for chromogranine and sustentacular cell
immune reaction for S100 protein [9]. In the interna-
tional Classification of Disease for Oncology (ICD-O),
paragangliomas of the cauda equina and filum terminale
are classified as "tumours of neuro-epithelial tissue" in the
sub-group of "Neuronal and Mixed Neuronal-Glial
Tumours" (8680/1 morphology code): In the WHO grad-
ing system they are classified as grade 1 [1,17]. The prog-
Sustentacular cells immunoreaction for S-100 protein Figure 7
Sustentacular cells immunoreaction for S-100 protein.
Immunohistochemical reactivity of chromogranine Figure 8
Immunohistochemical reactivity of chromogranine.Publish with BioMed Central    and   every 
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nosis of these lesions is good, as long as they are
completely removed. In fact, subtotal excision is not infre-
quently followed by local recurrence and even a distant
metastatic spread has been described [10]. Consequently,
prognosis is better in lesions that are well-encapsulated.
When complete removal is not feasible, radiotherapy may
be considered, although resistance to this form of treat-
ment has been documented [9]. As far as chemotherapy is
concerned, at the time being it does not appear to play a
role in the management of these lesions. The median free
interval between surgical removal and local recurrence is
estimated to be approximately 6 years [18]. However, the
fact that isolated cases of recurrence have been observed as
many as 20 years after surgical treatment [18] indicates
that an assiduous long-term follow-up is mandatory
whenever complete removal has not been achieved.
Conclusions
Paraganglioma of the filum terminale is an extremely
uncommon condition. It usually presents with low back
pain and radicular pain and may be accompanied by a
loss of strength in some cases. Magnetic resonance with
Gadolinium administration gives useful information for
surgical planning but is not diagnostic. The goal of surgi-
cal treatment is total resection of the lesion that guaran-
tees cure in the majority of cases. Patients in whom
complete removal is not feasible require assiduous long-
term follow-up.
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